SynopsisValacyclovir The global Valacyclovir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Valacyclovir is estimated to incre.....
SynopsisCefepime is a fourth-generation cephalosporin.Its antibacterial spectrum has been further expanded, and it has strong antibacterial activity against a variety of gram-positive and negative bacteria, including enterobacteria, pseudomonas aeruginosa and other no.....
SynopsisCefdinir, also known as Omnicef, is a semi-synthetic, broad-spectrum antibiotic belonging to the third generation of the cephalosporin class. It has been proven to be effective for the treatment of common bacterial infections in the ear, sinus, throat, lungs, .....
SynopsisLevonorgestrel is a hormonal medication which is used in a number of birth control methods. The global Levonorgestrel API market was valued at US$ 48 million in 2023 and is anticipated to reach US$ 63 million by 2030, witnessing a CAGR of 4.0% during the.....
SynopsisClomiphene is the most commonly used ovulatory stimulant in clinic. After taking this drug, through competition with estrogen, the negative feedback of estrogen to the hypothalamus is released, gonadotropin is released in the hypothalamus, gonadotropin is secr.....
SynopsisEthinylestradiol The global Ethinylestradiol market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Ethinylestradiol is estima.....
SynopsisMisoprostol is a prostaglandin analog used to reduce the risk of NSAID related ulcers, manage miscarriages, prevent post partum hemorrhage, and also for first trimester abortions. The global Misoprostol market was valued at US$ million in 2023 and is ant.....
SynopsisHuman chorionic gonadotropin (HCG), a polypeptide hormone produced by the human placenta. Endogenously produced HCG interacts with the LHCG receptor of the ovary and promotes the maintenance of the corpus luteum during the beginning of pregnancy. This allows t.....
SynopsisRaloxifene, primarily used to prevent and treat osteoporosis in postmenopausal women, has been shown to significantly reduce the incidence of vertebral fractures, but the reduction in hip fractures has not been demonstrated.When deciding on the use of raloxife.....
SynopsisMifepristone is a progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. The global Mif.....
